摘要
目的探讨水胶体敷料康惠尔透明贴在治疗非小细胞肺癌患者PICC置管术后机械性静脉炎中的作用和价值。方法将200例因PICC置管术后机械性导致的静脉炎(3级)的非小细胞肺癌患者随机分为水胶体敷料组和对照组各100例。在治疗10天后,对患者静脉炎的严重程度和疼痛水平进行分析。结果治疗10天后两组患者静脉炎均有改善,但水胶体敷料组较对照组改善更加显著,差异有统计学意义(χ2=13.723,P<0.05);水胶体敷料组患者疼痛水平较对照组更低,差异亦有统计学意义(χ2=16.052,P<0.05)。治疗过程中未见与药物相关的不良反应。结论水胶体敷料在治疗PICC置管术后机械性静脉炎疗效明确,且较硫酸镁湿敷效果更佳,具有一定临床推广应用价值。
Objective To investigate the therapeutical value of hydrocolloid dressing in the treatment of PICC-induced mechanic phlebitis in patients with non-small cell lung cancer （NSCLC）. Methods 200 NSCLC patients with PICC-induced mechanic phlebitis （degree 3） were randomly divided into hydrocolloid dressing treatment group （treatment group） and normal treatment group （control group）. After 10 days treatments, according to Infusion Nursing Standards of Practice （2006 version）, the severity of phlebitis were calculated. Meanwhile, after 10 days treatment, the severity of pain was also measured with Numeric Rating Scale （NRS） pain analysis system. Results After 10 days treatments, the severity of phlebitis were all improved in two groups. However, the improvement in treatment group was more significant than control group （x^2=13. 723, P〈0.05）. Meanwhile, at day 10, the severity of pain in treatment group was less severe than control group as well （x^2=16. 052, P〈0. 05）. Conclusions Hydrocolloid dressing was a safe and effective drug for the treatment of PICC-induced mechanic phlebitis in patients with non-small cell lung cancer （NSCLC）.
出处
《西部医学》
2014年第12期1714-1716,共3页
Medical Journal of West China
基金
河北省卫生厅重点科技研究计划(20130359)
关键词
非小细胞肺癌
机械性静脉炎
水胶体敷料
Non-small cell lung cancer
Peripherally inserted central catheter
Mechanical phlebitis
H ydrocolloid dressing
